Related Experiment Video
Updated: Apr 7, 2026

10:58
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
8.1K
Tailored immunogens for rationally designed antibody-based HIV-1 vaccines
1Laboratory of Humoral Response to Pathogens, Department of Immunology, Institut Pasteur, Paris, France; CNRS-URA 1961, Paris, France.
Trends in Immunology
|July 15, 2015
Abstract:
Protective HIV-1 vaccines would require the induction of broadly neutralizing antibodies (bNAbs) to be effective against the vast diversity of circulating viral strains. Three new studies provide in vivo demonstration that rational design of vaccine strategies using engineered and native-like HIV-1 immunogens can be exploited for guiding B-cell evolution towards the genesis of HIV-1 bNAbs.

